http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Prague, London, June 26, 2008 - Zentiva N.V. ("Zentiva" or the "Company") announces that it has been informed about the termination of the shareholders agreement between Sanofi-Aventis Europe and... http://pharmalicensing.com/redirs/news_rss//public/news/view/428822/1/termination-of-the-shareholders-agreement-between-sanofi-aventis-europe-and-certain-management-shareholders http://pharmalicensing.com/redirs/news_rss//public/news/view/428822/1/termination-of-the-shareholders-agreement-between-sanofi-aventis-europe-and-certain-management-shareholders (Lysaker, Norway, 26 June 2008) Navamedic's subsidiary Vitaflo Scandinavia has signed a prolonged marketing and distribution agreement with Bioplax for the product Aftamed. Vitaflo has marketed and... http://pharmalicensing.com/redirs/news_rss//public/news/view/428834/1/prolonged-marketing-and-distribution-agreement-for-aftamed http://pharmalicensing.com/redirs/news_rss//public/news/view/428834/1/prolonged-marketing-and-distribution-agreement-for-aftamed Mumbai, India: June 26, 2008: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that a subsidiary of Sun Pharma has exercised the... http://pharmalicensing.com/redirs/news_rss//public/news/view/428846/1/sun-pharmaceutical-exercises-its-options-to-acquire-the-shares-of-the-controlling-shareholders-of-taro-pharmaceuticals http://pharmalicensing.com/redirs/news_rss//public/news/view/428846/1/sun-pharmaceutical-exercises-its-options-to-acquire-the-shares-of-the-controlling-shareholders-of-taro-pharmaceuticals Thursday, June 26, 2008 -- Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical supplies, announced today that it has acquired Chester Labs, a leading... http://pharmalicensing.com/redirs/news_rss//public/news/view/428850/1/medline-acquires-chester-labs-chester-labs-to-continue-as-independent-operating-entity-under-new-name-of-chester-packaging-llc http://pharmalicensing.com/redirs/news_rss//public/news/view/428850/1/medline-acquires-chester-labs-chester-labs-to-continue-as-independent-operating-entity-under-new-name-of-chester-packaging-llc ST. PAUL, Minn. & WEST BERLIN, N.J.--June 26, 2008--St. Jude Medical, Inc. (NYSE: STJ) and EP MedSystems, Inc. (NASDAQ: EPMD) announced today that the deadline for EP MedSystems shareholders to elect... http://pharmalicensing.com/redirs/news_rss//public/news/view/428866/1/st-jude-medical-and-ep-medsystems-announce-cash-stock-election-deadline-and-expected-closing-date-of-pending-acquisition http://pharmalicensing.com/redirs/news_rss//public/news/view/428866/1/st-jude-medical-and-ep-medsystems-announce-cash-stock-election-deadline-and-expected-closing-date-of-pending-acquisition VANCOUVER, June 26, 2008 - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of... http://pharmalicensing.com/redirs/news_rss//public/news/view/428882/1/response-biomedical-corporation-announces-strategic-partnership-with-roche-diagnostics-to-commercialize-cardiovascular-tests http://pharmalicensing.com/redirs/news_rss//public/news/view/428882/1/response-biomedical-corporation-announces-strategic-partnership-with-roche-diagnostics-to-commercialize-cardiovascular-tests Stockholm, Sweden, June 26th 2008. The Swedish biopharmaceutical company BioArctic Neuroscience AB and Swenora Biotech AB, today announced that they have signed an exclusive licence agreement for a... http://pharmalicensing.com/redirs/news_rss//public/news/view/428890/1/bioarctic-neuroscience-and-swenora-biotech-enter-into-exclusive-licensing-agreement-for-a-novel-treatment-of-spinal-cord-injury http://pharmalicensing.com/redirs/news_rss//public/news/view/428890/1/bioarctic-neuroscience-and-swenora-biotech-enter-into-exclusive-licensing-agreement-for-a-novel-treatment-of-spinal-cord-injury WORCESTER, MA, June 26, 2008 -- Antigen Express, Inc. (www.antigenexpress.com), the wholly-owned immunotherapeutics subsidiary of Generex Biotechnology Corporation (NasdaqCM:GNBT, www.generex.com),... http://pharmalicensing.com/redirs/news_rss//public/news/view/428908/1/generex-biotechnology-expands-mayo-clinic-collaboration-for-vaccine-studies http://pharmalicensing.com/redirs/news_rss//public/news/view/428908/1/generex-biotechnology-expands-mayo-clinic-collaboration-for-vaccine-studies OBERKOCHEN/Germany, 26.06.2008--Carl Zeiss SMT, the world's leading manufacturer of optical systems for chip fabrication has designated SCHOTT Lithotec, a division of SCHOTT AG, as a Carl Zeiss SMT... http://pharmalicensing.com/redirs/news_rss//public/news/view/428928/1/carl-zeiss-designates-schott-lithotec-as-a-supply-chain-partner http://pharmalicensing.com/redirs/news_rss//public/news/view/428928/1/carl-zeiss-designates-schott-lithotec-as-a-supply-chain-partner In the meeting held on June 26, 2008, the board of directors of NIPRO CORPORATION resolved to merge Shinwa Shoji Co., Ltd. ("Shinwa Shoji"), its wholly owned consolidated subsidiary, into NIPRO... http://pharmalicensing.com/redirs/news_rss//public/news/view/428933/1/merger-of-consolidated-subsidiary-simplified-short-form-merger http://pharmalicensing.com/redirs/news_rss//public/news/view/428933/1/merger-of-consolidated-subsidiary-simplified-short-form-merger